Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition…
Pfizers Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Nave, High-Risk Non-Muscle Invasive Bladder Cancer
Pivotal Phase 3 CREST trial results show a 32% reduction in the…
KuCoin Achieves SOC 2 Type II Certification: Strengthening Security and Compliance Standards
VICTORIA, Seychelles, April 4, 2025 /PRNewswire/ -- KuCoin, a leading global cryptocurrency…
PolarFire SoC FPGAs Achieve AEC-Q100 Qualification
The robust, low-power solutions from Microchip Technology meet stringent automotive standards for…
CYREBRO’s AI-Native MDR Platform Earns Silver at the 2025 Globee Cybersecurity Awards
TEL AVIV, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- CYREBRO, the AI-native…
BCMI Achieves SOC 2 Type 2 Certification
REDMOND, Wash., March 06, 2025 (GLOBE NEWSWIRE) -- BCMI, software developer for…
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader…
IDfy Completes SOC 2 Type II Attestation, Strengthening Data Security and Operational Excellence
MUMBAI, India, Feb. 28, 2025 /PRNewswire/ -- IDfy, India's leading identity verification…
c/side Achieves SOC 2 Type II Compliance
SAN FRANCISCO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- c/side, a cybersecurity company…
Nanoprecise Sci Corp. Renews SOC 2 Type 2 Certification, Reinforcing Commitment to Security Excellence
EDMONTON, AB, Feb. 5, 2025 /PRNewswire/ -- Nanoprecise Sci Corp., a global leader…